Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses

Overview of attention for article published in BMC Cardiovascular Disorders, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis

Article in BMC Gastroenterology (September 2023)

Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies

Article in EP Europace (September 2023)

Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Article in The Korean Journal of Internal Medicine (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.